TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

NCT03617939 ·Status: RECRUITING

ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy

NCT05630131 ·Status: COMPLETED

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069 ·Status: RECRUITING

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

NCT03707574 ·Status: COMPLETED

Circulating Tumor DNA Exposure in Peripheral Blood

NCT03517332 ·Status: UNKNOWN

A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care

NCT02279004 ·Status: ACTIVE_NOT_RECRUITING

Development and Application of Patient-Derived Models of Cancer

NCT07226180 ·Status: ENROLLING_BY_INVITATION

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401 ·Status: ACTIVE_NOT_RECRUITING

Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"

NCT03071809 ·Status: TERMINATED

Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy

NCT01869218 ·Status: COMPLETED

Tissue Microarrays (TMAs) Construction in Lung Cancer Samples

NCT03136523 ·Status: COMPLETED

Medical Data Collection in the Formation of Precision Oncology Registry

NCT03874065 ·Status: TERMINATED

Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma

NCT03361358 ·Status: COMPLETED

Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients

NCT02626039 ·Status: COMPLETED

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

NCT00026663 ·Status: COMPLETED

Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC

NCT03302325 ·Status: COMPLETED

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

NCT04883827 ·Status: COMPLETED

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592 ·Status: RECRUITING

Caris Biorepository Research Protocol

NCT01499394 ·Status: RECRUITING

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR Kit

NCT05360225 ·Status: COMPLETED

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing

NCT04213326 ·Status: COMPLETED

Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

NCT06744296 ·Status: RECRUITING

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

NCT03662204 ·Status: COMPLETED

Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples

NCT01703585 ·Status: COMPLETED

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.

NCT05083494 ·Status: UNKNOWN